MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Acorda Therapeutics Company Profile (NASDAQ:ACOR)

Consensus Ratings for Acorda Therapeutics (NASDAQ:ACOR) (?)
Ratings Breakdown: 7 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Hold (Score: 2.36)
Consensus Price Target: $47.38 (40.87% upside)

Analysts' Ratings History for Acorda Therapeutics (NASDAQ:ACOR)
Show:
DateFirmActionRatingPrice TargetActions
2/12/2016Stifel NicolausReiterated RatingBuy$53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016Leerink SwannReiterated RatingMarket Perform$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2016Cowen and CompanyReiterated RatingOutperform$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/11/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2016AegisBoost Price TargetBuy$40.00 -> $52.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/23/2015AegisReiterated RatingBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/22/2015JPMorgan Chase & Co.Reiterated RatingHold$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/5/2015Leerink SwannReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/5/2015Cowen and CompanyReiterated RatingBuy$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/1/2015AegisInitiated CoverageBuy$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/31/2015Raymond JamesInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2015Stifel NicolausReiterated RatingBuy$47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2015Cowen and CompanyReiterated RatingOutperform$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/25/2015JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015Canaccord GenuityReiterated RatingHold$32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/31/2015JPMorgan Chase & Co.Reiterated RatingNeutral$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2015Cowen and CompanyReiterated RatingOutperform$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015MLV & Co.Set Price TargetBuy$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2015GuggenheimInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/27/2015Canaccord GenuityReiterated RatingHold$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/15/2015Canaccord GenuityReiterated RatingHold$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015JPMorgan Chase & Co.Reiterated RatingNeutral$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/1/2015Canaccord GenuityReiterated RatingHold$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/22/2015Piper JaffrayInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/15/2015JPMorgan Chase & Co.Reiterated RatingNeutral$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/15/2015Canaccord GenuityReiterated RatingHold$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/13/2015Citigroup Inc.Reiterated RatingHold$46.00 -> $42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/12/2015MLV & Co.Initiated CoverageBuy$58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015RBC CapitalSet Price TargetBuy$45.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/13/2015Citigroup Inc.Reiterated RatingHold$36.00 -> $46.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2015JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015JPMorgan Chase & Co.Set Price TargetHold$42.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/26/2014AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2014Goldman SachsInitiated CoverageNeutral$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/31/2014FBR & Co.Reiterated RatingOutperform$57.00 -> $59.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/31/2014Citigroup Inc.Reiterated RatingNeutral$34.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2014MKM PartnersBoost Price TargetNeutral$31.50 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014Stifel NicolausInitiated CoverageBuy$47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014MKM PartnersLower Price TargetNeutral$33.00 -> $31.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2014AegisReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/5/2014Citigroup Inc.Reiterated RatingHold$34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2014Canaccord GenuityInitiated CoverageHold$37.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/14/2014FBR & Co.UpgradeMarket Perform -> Outperform$30.00 -> $47.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/13/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha